These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2699126)

  • 41. Role of uremic toxins in exacerbating anemia in renal failure.
    Macdougall IC
    Kidney Int Suppl; 2001 Feb; 78():S67-72. PubMed ID: 11168986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
    Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
    Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Renal anemia. Its diagnosis, pathogenesis, compensation and therapy in childhood].
    Müller-Wiefel DE
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):72-9. PubMed ID: 6374430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherosclerotic complications in chronic renal failure: epidemiology and predictive factors.
    Jungers P; Nguyen Khoa T; Joly D; Choukroun G; Witko-Sarsat V; Massy ZA
    Adv Nephrol Necker Hosp; 2000; 30():177-99. PubMed ID: 11068642
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pathogenetic treatment of nephrogenic anemia].
    Riabov SI; Shostka GD; Vinogradova TV
    Ter Arkh; 1977; 49(9):98-102. PubMed ID: 929429
    [No Abstract]   [Full Text] [Related]  

  • 46. SEM studies of erythrocyte shape as an indicator of erythrocyte function.
    Dardano JR; Kimzey SL
    Scan Electron Microsc; 1979; (3):809-14, 800. PubMed ID: 524049
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis of renal anemia.
    Nangaku M; Eckardt KU
    Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of chronic uremia in childhood. II. Hemodialysis.
    Potter D; Larsen D; Leumann E; Perin D; Simmons J; Piel CF; Holliday MA
    Pediatrics; 1970 Nov; 46(5):678-89. PubMed ID: 4921218
    [No Abstract]   [Full Text] [Related]  

  • 50. [High-molecular compounds in the erythropoietic disorder of patients in the terminal stage of chronic kidney failure].
    Gudim VI; Sukiasova TG; Ivanova VS; Gorbunova NA; Kozinets GI
    Patol Fiziol Eksp Ter; 1985; (6):66-71. PubMed ID: 4094808
    [No Abstract]   [Full Text] [Related]  

  • 51. The anemia of renal failure: the role of the hexose monophosphate shunt.
    Tet-Ken-Voo R
    Can J Med Technol; 1973 Oct; 35(5):14 passim. PubMed ID: 4756807
    [No Abstract]   [Full Text] [Related]  

  • 52. Anemia of renal failure.
    Fried W
    Med Clin North Am; 1971 Jan; 55(1):3-9. PubMed ID: 4923435
    [No Abstract]   [Full Text] [Related]  

  • 53. Erythropoiesis in anephric or kidney transplanted patients.
    Nakao K; Takaku F; Chiba S
    Isr J Med Sci; 1971; 7(7):986-90. PubMed ID: 4943623
    [No Abstract]   [Full Text] [Related]  

  • 54. [Behavior and significance of plasmatic erythropoietin in anemias in the course of chronic renal insufficiency].
    Gambaro GC; Fresco G; Aranzulla G; De Ferrari G; Gurreri G
    Arch Maragliano Patol Clin; 1970; 26(3):181-97. PubMed ID: 5538115
    [No Abstract]   [Full Text] [Related]  

  • 55. Anemia therapy in ESRD: time to move on.
    Folkert VW; Meyer TW; Hostetter TH
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1163-4. PubMed ID: 20538832
    [No Abstract]   [Full Text] [Related]  

  • 56. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure.
    Malgor LA; Barrios L; de Albarenque MV; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Acta Physiol Pharmacol Latinoam; 1987; 37(3):365-76. PubMed ID: 3503475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regression of uremia-induced suppression of erythropoiesis in patients with chronic kidney disease].
    Uhl N; Rehn K
    Verh Dtsch Ges Inn Med; 1974; 80():755-7. PubMed ID: 4454655
    [No Abstract]   [Full Text] [Related]  

  • 58. [Erythropoietin, a milestone in the history of nephrology].
    Uehlinger DE; Frey FJ
    Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 60. Anemia management in patients with chronic conditions that affect erythropoiesis. Case study of the anemic patients.
    Deziel SM
    Nephrol Nurs J; 2002 Dec; 29(6):582-5. PubMed ID: 12596607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.